1. 09.02 Bispecific antibodies enable synthetic agonistic receptor T cell therapy in melanoma. (21st September 2022) Authors: Benmebarek, M; Märkl, F; Keyl, J; Cadilha, B; Geiger, M; Karches, C; Obeck, H; Schwerdtfeger, M; Briukhovetska, D; Jobst, J; Müller, PJ; Seifert, M; Grünmeier, R; Thomas, M; Marr, C; Levesque, M; Heppt, M; Endres, S; Klein, C; Kobold, S Journal: Journal for immunotherapy of cancer Issue: Volume 10(2022)Supplement 1 Page Start: A4 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 52PA novel rMVA combination immunotherapy triggers potent innate and adaptive immune responses against established tumors. (5th March 2018) Authors: Medina, J; Hinterberger, M; Testori, M; Geiger, M; Giessel, R; Chaplin, P; Hochrein, H; Lauterbach, H Journal: Annals of oncology Issue: Volume 29(2018)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Exceptional Changes in Skeletal Anatomy under Domestication: The Case of Brachycephaly. Issue 1 (16th August 2021) Authors: Geiger, M; Schoenebeck, J J; Schneider, R A; Schmidt, M J; Fischer, M S; Sánchez-Villagra, M R Journal: Integrative organismal biology Issue: Volume 3:Issue 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P04.02 A novel cancer immunotherapy combines rMVA-CD40L with tumor targeting antibodies. (1st October 2020) Authors: Hinterberger, M; Medina-Echeverz, J; Testori, M; Geiger, M; Giessel, R; Bathke, B; Kassub, R; Gräbnitz, F; Fiore, G; Wennier, S; Chaplin, P; Suter, M; Hochrein, H; Lauterbach, H Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 2 Page Start: A37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P045 Local administration of extracellular vesicles from adipose-derived stromal cells promote healing in a rat model of radiation colitis – a pilot study. (30th January 2023) Authors: Sebbagh, A; Mathieu, N; Demarquay, C; Geiger, M; Sémont, A; Simon, C; Branchu, J; Milliat, F; Gazeau, F; Wilhelm, C; Silva Brun, A; Rahmi, G Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i212 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P06.01 Bispecific antibody-driven synthetic agonistic receptor – transduced T cells mediate specific and conditional therapy in melanoma cancer models. (1st October 2020) Authors: Benmebarek, M; Keyl, J; Märkl, F; Geiger, M; Karches, C; Rausch, S; Gottschlich, A; Öner, A; Feinendegen, M; Dörr, J; Cadilha, B; Endres, S; Klein, C; Kobold, S Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 2 Page Start: A41 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗